RIO DE JANEIRO, BRAZIL - Minister of Science, Technology and Innovation Roberto Salvarezza said Tuesday (17) that next year at least one of the vaccines against the coronavirus being developed in Argentina could begin clinical phase trials, i.e. on humans.
"We expect to start phase 1 and 2 human trials next year. This year we are completing the pre-clinical phase," Salvarezza said.
The Minister recalled that although "there are Argentine vaccine projects in the pre-clinical phase," one of them is "very advanced, being developed at the San Martín University (UNSAM) with CONICET and Cassará laboratory researchers."
Salvarezza . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here